Following this line of development that tends to make antibody molecules smaller in size but with similar biological properties, we tested the feasibility of making a humanized Fab derived from the murine anti-Nodal antibody 3D1 already well-characterized for its ability to neutralize the Nodal activity in in vivo tumor models. The gene discussed is NODAL; the disease is neoplasm.